As of 2025-09-18, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 28.61 USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.20 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 18.2%.
The range of the Relative Valuation is 19.41 - 34.63 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 18.3x | 18.1x |
| Forward P/E multiples | 15.2x - 20.1x | 19.4x |
| Fair Price | 19.41 - 34.63 | 28.61 |
| Upside | -19.8% - 43.1% | 18.2% |
| Date | P/E |
| 2025-09-17 | 18.38 |
| 2025-09-16 | 18.20 |
| 2025-09-15 | 18.73 |
| 2025-09-12 | 17.93 |
| 2025-09-11 | 18.38 |
| 2025-09-10 | 18.07 |
| 2025-09-09 | 18.86 |
| 2025-09-08 | 19.28 |
| 2025-09-05 | 19.18 |
| 2025-09-04 | 19.36 |
| 2025-09-03 | 19.53 |
| 2025-09-02 | 19.51 |
| 2025-08-29 | 19.74 |
| 2025-08-28 | 19.92 |
| 2025-08-27 | 20.18 |
| 2025-08-26 | 19.53 |
| 2025-08-25 | 19.23 |
| 2025-08-22 | 19.55 |
| 2025-08-21 | 18.82 |
| 2025-08-20 | 18.94 |
| 2025-08-19 | 18.96 |
| 2025-08-18 | 19.03 |
| 2025-08-15 | 19.24 |
| 2025-08-14 | 18.63 |
| 2025-08-13 | 19.08 |
| 2025-08-12 | 19.33 |
| 2025-08-11 | 18.85 |
| 2025-08-08 | 18.68 |
| 2025-08-07 | 18.53 |
| 2025-08-06 | 18.07 |
| 2025-08-05 | 17.95 |
| 2025-08-04 | 18.26 |
| 2025-08-01 | 17.87 |
| 2025-07-31 | 18.10 |
| 2025-07-30 | 17.87 |
| 2025-07-29 | 17.19 |
| 2025-07-28 | 17.18 |
| 2025-07-25 | 17.66 |
| 2025-07-24 | 17.50 |
| 2025-07-23 | 17.67 |
| 2025-07-22 | 17.14 |
| 2025-07-21 | 16.92 |
| 2025-07-18 | 17.13 |
| 2025-07-17 | 17.12 |
| 2025-07-16 | 17.12 |
| 2025-07-15 | 16.71 |
| 2025-07-14 | 16.62 |
| 2025-07-11 | 15.93 |
| 2025-07-10 | 16.75 |
| 2025-07-09 | 16.38 |